Missouri legislation · 2025 Regular Session
Missouri HB165: Modifies provisions relating to epinephrine products
Status: In committee, May 15, 2025
What the bill says
From the introduced text:
FIRST REGULAR SESSION HOUSE BILL NO. 103RD GENERAL ASSEMBLY INTRODUCED BY REPRESENTATIVE SPARKS. 0281H.01I DANARADEMANMILLER,ChiefClerk To repeal sections 167.627, 167.630, 190.246, 196.990, and 321.621, RSMo, and to enact in lieu thereof five new sections relating to epinephrine products, with penalty provisions. Section A. Sections 167.627, 167.630, 190.246, 196.990, and 321.621, RSMo, are repealed and five new sections enacted in lieu thereof, to be known as sections 167.627, 167.630, 190.246, 196.990, and 321.621, to read as follows: 167.627. 1. For purposes of this section, the following terms shall mean: (1) "Medication",anymedicineprescribedororderedbyaphysicianforthetreatment of asthma or anaphylaxis, including without limitation inhaled bronchodilators [and], autoinjectible epinephrine, and single-use epinephrine nasal spray; (2) "Self-administration", a pupil's discretionary use of medication prescribed by a physician or under a written treatment plan from a physician. 2. Each board of education and its employees and agents in this state shall grant any pupil in the school authorization for the possession and self-administration of medication to treat such pupil's chronic health condition, including but not limited to asthma or anaphylaxis if: (1) A licensed physician prescribed or ordered such medication for use by the pupil and instructed such pupil in the correct and responsible use of such medication; (2) The pupil has demonstrated to the pupil's licensed physician or the licensed physician's designee, and the school nurse, if available, …
Sponsors
- Sparks, Justin (R) · primary sponsor
Latest actions
- : Referred: Emerging Issues(H)
- : Read Second Time (H)
- : Read First Time (H)
- : Prefiled (H)
Common questions
- What is HB165?
- HB165 is a bill in the Missouri Legislature (2025 Regular Session): Modifies provisions relating to epinephrine products.
- What is the status of HB165?
- In committee as of May 15, 2025. Latest action: Referred: Emerging Issues(H) (May 15, 2025).
- Who sponsored HB165?
- Sparks, Justin (R).
- Where is the official record for HB165?
- On the Missouri Legislature website: https://house.mo.gov/BillContent.aspx?bill=HB165&year=2025&code=R
Source: official Missouri record. Tracked by Delilah, AI for legislation across all 50 states and Congress.